Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in Giant Cell Arteritis
NCT00430807Phase 3Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jan 2002
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in giant cell arteritis (GCA), sponsored by Centre hospitalier universitaire de Toulouse. Started Jan 2002; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
giant cell arteritis (GCA)
Beyond the preview
Go deeper on NCT00430807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430807.